Therefore, it is imperative to understand the molecular underpinnings of the T835M mutation in UNC5C-related brain atrophy and neuronal cell death to inform the potential of UNC5C as a therapeutic target for AD. The gene discussed is UNC5C; the disease is Alzheimer disease.